← Back to headlines
Cytokinetics Launches MYQORZO in Germany for Obstructive HCM Treatment
Cytokinetics (CYTK) has introduced its drug MYQORZO in Germany, intended for the treatment of obstructive hypertrophic cardiomyopathy (HCM).
13 Jun, 19:34 — 13 Jun, 19:34
Sources
Showing 1 of 1 sources
Related Stories
OpenAI Terminates Partnership With SpaceX-Backed AI Tool Cursor
28m ago
NASA to launch $4.3bn Roman space telescope to study dark matter and exoplanets
50m ago
Widow Files Lawsuit Against Singapore Airlines Over Turbulence Fatality
1h ago
Nepal flood damage could cost up to a tenth of economy to rebuild
1h ago